Entry
Name
Wnt signaling pathway - Puma yagouaroundi (jaguarundi)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
BRITE hierarchy
Pathway map
Other DBs
Organism
Puma yagouaroundi (jaguarundi) [GN:
pyu ]
Gene
121010989 FBXW11; F-box/WD repeat-containing protein 11 isoform X1 [KO:K03362 ]
121012476 PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
121012479 PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
121014670 BAMBI; BMP and activin membrane-bound inhibitor homolog [KO:K10162 ]
121015239 SFRP1; secreted frizzled-related protein 1 isoform X1 [KO:K02166 ]
121016029 DVL2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353 ]
121016945 CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
121017559 RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392 ]
121019071 DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353 ]
121019973 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332 ]
121021565 LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1 [KO:K08399 ]
121021785 NKD2; LOW QUALITY PROTEIN: protein naked cuticle homolog 2 [KO:K03213 ]
121023741 LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068 ]
121023937 PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
121025903 PRICKLE3; prickle planar cell polarity protein 3 isoform X1 [KO:K04511 ]
121028906 SFRP4; secreted frizzled-related protein 4 isoform X1 [KO:K02185 ]
121029333 PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504 ]
121029406 DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512 ]
121030635 CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
121031434 CHD8; chromodomain-helicase-DNA-binding protein 8 isoform X1 [KO:K04494 ] [EC:5.6.2.-]
121031578 NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 [KO:K17334 ]
121031838 DAAM1; disheveled-associated activator of morphogenesis 1 isoform X1 [KO:K04512 ]
121031929 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
121032920 SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501 ]
121033234 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446 ]
121034012 TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508 ]
121034071 DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353 ]
121036791 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
121036802 CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
121037122 LZTS2; leucine zipper putative tumor suppressor 2 isoform X1 [KO:K26471 ]
121037135 BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362 ]
121038918 LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068 ]
121039868 CCAR2; cell cycle and apoptosis regulator protein 2 isoform X1 [KO:K25816 ]
121039877 PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
121040395 RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860 ]
121040744 LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 isoform X1 [KO:K04308 ]
121041495 PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858 ] [EC:3.1.4.11 ]
121041878 SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605 ]
121043627 LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 [KO:K04309 ]
121045049 CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
121045484 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X4 [KO:K17333 ]
Compound
Reference
Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
Title
Beta-catenin and Tcfs in mammary development and cancer.
Journal
Reference
Authors
Yang Y.
Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
Journal
Reference
Authors
Kalderon D.
Title
Similarities between the Hedgehog and Wnt signaling pathways.
Journal
Reference
Authors
Nusse R.
Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
Journal
Reference
Authors
Jope RS, Johnson GV.
Title
The glamour and gloom of glycogen synthase kinase-3.
Journal
Reference
Authors
Veeman MT, Axelrod JD, Moon RT.
Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
Journal
Reference
Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
Journal
Reference
Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
Title
The way Wnt works: Components and mechanism.
Journal
Reference
Authors
Carethers JM
Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
Journal
Reference
Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
Journal
Reference
Authors
Niehrs C
Title
The complex world of WNT receptor signalling.
Journal
Reference
Authors
Abou Ziki MD, Mani A
Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
Journal
Reference
Authors
He Y, Ki H, Kim H, Kim K
Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
Journal
Reference
Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
Journal
Reference
Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
Journal
Related pathway
KO pathway